News | February 22, 2021

Monique Mendoza Promoted To Head Of Quality At Pharmaceutics International, Inc. (Pii)

Hunt Valley, MD — Ms. Monique Mendoza has been promoted to Head of Quality for Pharmaceutics International, Inc. (Pii).

In her new, promoted role, Ms. Mendoza will be responsible for the entire Quality unit at Pii and report directly to the President and Chief Executive Officer, Dr. Kurt Nielsen. Her scope of responsibilities includes: Sterility Assurance, Batch Disposition, Investigations, Change Controls, Product Complaints, Supplier Qualification, Raw Material Release, Audits (internal, external and client), Document Control, and Quality Control across all facilities including Microbiology Laboratories.

“I am very excited about Monique’s new role and what it means to the future of our organization,” says Dr. Nielsen. “Monique is a gifted leader who has been instrumental in shaping Pii’s quality systems. Her dedication to continuous improvement and ensuring quality is the foundation of everything we do is second to none. In her new role, she immediately becomes a valuable asset to our executive team as well as our clients and the patients who rely on the medicines we develop and produce.”

Monique has over 20 years of experience in the pharmaceutical/biotechnology industry. ​Prior to joining Pii, Monique served as Director of Quality for Dynavax Technologies both domestically and internationally. She also worked for Bayer Healthcare for over 15 years with increasing responsibilities in both Manufacturing and QA. Monique earned her B.S. from the University of the Pacific.

Pharmaceutics International, Inc. (Pii) is a US-based contract development and manufacturing organization (CDMO) with a passion for solving problems. Pii’s Hunt Valley, Maryland campus includes 70 manufacturing suites with four integrated aseptic filling lines delivering quality, safety, and efficiency. Our professionals have extensive experience with small and large molecule compounds, developing and manufacturing complex parenteral drugs, extended-release formulations, non-aqueous injectable drug products, and lyophilization. Learn more at https://www.pharm-int.com/.